No Data
No Data
No Data
No Data
No Data
ResMed Keeps Bull Amid Weight-Loss Drug Trials -- Market Talk
0123 GMT - Breathing-tech manufacturer ResMed keeps its bull at Jarden following drugmaker Eli Lilly's weight-loss drug trial results that the investment advisor's analysts say were largely as anticip
WSJApr 18 21:23 ET
ResMed's 3Q Profit to Beat Market Expectations -- Market Talk
0026 GMT - Breathing-tech provider ResMed's 3Q profit is likely to beat market expectations, Macquarie analysts tell clients in a note. They anticipate a March-quarter net profit of US$292 million on
WSJApr 18 20:26 ET
ResMed Target Price Raised 2.5% to A$34.30/Share by Macquarie>RMD.AU
ResMed Target Price Raised 2.5% to A$34.30/Share by Macquarie>RMD.AU
Dow JonesApr 18 19:01 ET
ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Yahoo FinanceApr 18 10:01 ET
Why Evolution Mining, Karoon Energy, ResMed, and Sayona Mining Shares Are Dropping Today
The Motley FoolApr 18 00:06 ET
Why Is the ResMed Share Price Diving 5% Today?
The Motley FoolApr 17 21:44 ET
No Data
No Data